sulfasalazine has been researched along with Bone Diseases in 1 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Bone Diseases: Diseases of BONES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kita, J | 1 |
| Tamai, M | 1 |
| Arima, K | 1 |
| Kawashiri, SY | 1 |
| Horai, Y | 1 |
| Iwamoto, N | 1 |
| Okada, A | 1 |
| Koga, T | 1 |
| Nakashima, Y | 1 |
| Suzuki, T | 1 |
| Yamasaki, S | 1 |
| Nakamura, H | 1 |
| Origuchi, T | 1 |
| Ida, H | 1 |
| Aoyagi, K | 1 |
| Uetani, M | 1 |
| Eguchi, K | 1 |
| Kawakami, A | 1 |
1 other study available for sulfasalazine and Bone Diseases
| Article | Year |
|---|---|
Significant improvement in MRI-proven bone edema is associated with protection from structural damage in very early RA patients managed using the tight control approach.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Bone Diseases; Disease Progression; Edema; | 2013 |